Neuronal ceroid lipofuscinoses are connected at molecular level:: Interaction of CLN5 protein with CLN2 and CLN3

被引:90
作者
Vesa, J
Chin, MH
Oelgeschläger, K
Isosomppi, J
DellAngelica, EC
Jalanko, A
Peltonen, L [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Gonda Neurosci & Genet Res Ctr, Dept Human Genet, Los Angeles, CA 90095 USA
[2] Natl Publ Hlth Inst, Acad Finland, Biomedicum, Dept Mol Med, FIN-00300 Helsinki, Finland
[3] Natl Publ Hlth Inst, Acad Finland, Biomedicum, Ctr Excellence Dis Genet, FIN-00300 Helsinki, Finland
关键词
D O I
10.1091/mbc.E02-01-0031
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Neuronal ceroid lipofuscinoses (NCLs) are neurodegenerative storage diseases characterized by mental retardation, visual failure, and brain atrophy as well as accumulation of storage material in multiple cell types. The diseases are caused by mutations in the ubiquitously expressed genes, of which six are known. Herein, we report that three NCL disease forms with similar tissue pathology are connected at the molecular level: CLN5 polypeptides directly interact with the CLN2 and CLN3 proteins based on coimmunoprecipitation and in vitro binding assays. Furthermore, disease mutations in CLN5 abolished interaction with CLN2, while not affecting association with CLN3. The molecular characterization of CLN5 revealed that it was synthesized as four precursor forms, due to usage of alternative initiator methionines in translation. All forms were targeted to lysosomes and the longest form, translated from the first potential methionine, was associated with membranes. Interactions between CLN polypeptides were shown to occur with this longest, membrane-bound form of CLN5. Both intracellular targeting and posttranslational glycosylation of the polypeptides carrying human disease mutations were similar to wild-type CLN5.
引用
收藏
页码:2410 / 2420
页数:11
相关论文
共 30 条
  • [1] An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains
    Aaltonen, J
    Bjorses, P
    Perheentupa, J
    HorelliKuitunen, N
    Palotie, A
    Peltonen, L
    Lee, YS
    Francis, F
    Hennig, S
    Thiel, C
    Lehrach, H
    Yaspo, ML
    [J]. NATURE GENETICS, 1997, 17 (04) : 399 - 403
  • [2] ANDERSSON S, 1989, J BIOL CHEM, V264, P8222
  • [3] AP-3: An adaptor-like protein complex with ubiquitous expression
    DellAngelica, EC
    Ohno, H
    Ooi, CE
    Rabinovich, E
    Roche, KW
    Bonifacino, JS
    [J]. EMBO JOURNAL, 1997, 16 (05) : 917 - 928
  • [4] Expression of palmitoyl protein thioesterase in neurons
    Heinonen, O
    Kyttälä, A
    Lehmus, E
    Paunio, T
    Peltonen, L
    Jalanko, A
    [J]. MOLECULAR GENETICS AND METABOLISM, 2000, 69 (02) : 123 - 129
  • [5] Human palmitoyl protein thioesterase: Evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis
    Hellsten, E
    Vesa, J
    Olkkonen, VM
    Jalanko, A
    Peltonen, L
    [J]. EMBO JOURNAL, 1996, 15 (19) : 5240 - 5245
  • [6] SOSUI: classification and secondary structure prediction system for membrane proteins
    Hirokawa, T
    Boon-Chieng, S
    Mitaku, S
    [J]. BIOINFORMATICS, 1998, 14 (04) : 378 - 379
  • [7] Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs)
    Holopainen, JM
    Saarikoski, J
    Kinnunen, PKJ
    Järvelä, I
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (22): : 5851 - 5856
  • [8] Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein
    Isosomppi, J
    Vesa, J
    Jalanko, A
    Peltonen, L
    [J]. HUMAN MOLECULAR GENETICS, 2002, 11 (08) : 885 - 891
  • [9] Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)
    Järvelä, I
    Lehtovirta, M
    Tikkanen, R
    Kyttälä, A
    Jalanko, A
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (06) : 1091 - 1098
  • [10] Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease
    Järvelä, I
    Sainio, M
    Rantamäki, T
    Olkkonen, VM
    Carpén, O
    Peltonen, L
    Jalanko, A
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (01) : 85 - 90